Metraipolis › archive › dc_7dcee6c793df

Safety and Efficacy of Anti-B-cell Maturation Antigen (Anti-BCMA) Bispecific Antibodies for Relapsed/Refractory Multiple Myeloma: A Systematic Review of… — Europe PMC PMID:41357724

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41357724
DOI
10.7759/cureus.98368
License (as archived)
solo-consultazione
Archived
2026-11-07T23:51:57.412Z
SHA-256 of the archived text
6fa58926fee862f7cee63fc65ebc7d34330707e87145a64c56f3c9ffb1026c0e
Stable URL of this page
https://metraipolis.com/documento/dc_7dcee6c793df

How to cite

Safety and Efficacy of Anti-B-cell Maturation Antigen (Anti-BCMA) Bispecific Antibodies for Relapsed/Refractory Multiple Myeloma: A Systematic Review of… — Europe PMC PMID:41357724 — Europe PMC (en), https://europepmc.org/article/MED/41357724 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7dcee6c793df (Metraipolis archive dc_7dcee6c793df, sha256 6fa58926fee862f7cee63fc65ebc7d34330707e87145a64c56f3c9ffb1026c0e)
BibTeX
@misc{dc7dcee6c793df,
  title = {Safety and Efficacy of Anti-B-cell Maturation Antigen (Anti-BCMA) Bispecific Antibodies for Relapsed/Refractory Multiple Myeloma: A Systematic Review of… — Europe PMC PMID:41357724},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41357724},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7dcee6c793df; sha256 6fa58926fee862f7cee63fc65ebc7d34330707e87145a64c56f3c9ffb1026c0e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41357724. Agents can read the archived copy with the MCP tool read_document.